blog

We are excited to introduce one of our dynamic keynote panelists, Linda A. Glaser, MD, PhD of Coastal Biomedical Research, Inc. in Santa Monica, CA.

Linda will be sharing her site voice and insights at BBK’s Pharma15 Live! debate series at the 10^th Annual SCOPE Summit on Feb 19.

While pursuing a successful career in private practice, Linda’s passion for research lead her to establish Coastal Biomedical Research, Inc. in Santa Monica. The practice specializes in clinical trials across many therapies, from diabetes to hypertension to pain management. As Medical Director, she understands the patient experience and medical site needs. As a business owner, she also understands the importance of adaptability, efficiencies and overcoming operational challenges.

What is most rewarding to you as you consider your contribution to clinical trial research?

The ability to help advance science and treat disease.

How do you define patient engagement? What does that term mean to you?

Topics: Pharma15, clinical research, Patient Recruitment, Patient Retention, Physician Engagement, Conferences, Site Engagement, Patient Experience

BBK’s signature Pharma15 Live! web series is coming to the 10th Annual SCOPE Summit for Clinical Ops Executives. On February 19, Bonnie A. Brescia, BBK’s founding principal, will moderate a panel during the conference’s plenary keynote program on the topic of “Do Engagement Tools Live Up to Their Hype?” 

We are pleased to introduce one of our panelists, Gerald Wayne Dryden, Jr., MD, PhD, MSPH, MSc of University of Louisville, Kentucky.

Dr. Gerald “Tad” Dryden is Professor of Medicine and Director of the Inflammatory Bowel Disease Program in the Division of Gastroenterology at the University of Louisville in Louisville, KY.  He earned his MD at the University of Kentucky College of Medicine in Lexington, KY, and completed his internal medicine internship and residency at the Naval Medical Center in Portsmouth, VA. He then completed his gastroenterology fellowship at the Naval Medical Center in San Diego, CA.  During his tenure at the University of Louisville, he earned a Master of Science in Public Health, a Master of Science in Microbiology and Immunology, and a PhD in Microbiology and Immunology. Dr. Dryden’s research interests include developing new therapies from botanical sources and new medical devices to improve endoscopic care.

What is most rewarding to you as you consider your contribution to clinical trial research?

It is very rewarding when I am involved with a drug from the ground up -- seeing research patients benefit from the drug, then eventually being able to prescribe it to my clinic patients.

Topics: Patient Recruitment, Patient Retention, Patient Engagement, Pharma15, Patient, Site Support, Physician Referrals, Patient Experience

So much of the focus of clinical trial participation is on the patient and reducing site staff burden. But sometimes we forget about the role of the caregiver. After all, it is usually the caregiver driving the patient to their appointments, managing medication schedules, taking notes at doctor’s appointments, and much more. It makes you wonder: who is the caregiver’s caregiver? Enter Zaggo, a non-profit organization that provides the tools caregivers need to take care of their loved one as effectively and efficiently as possible.

Zaggo was born out of the experience of its founder and president, Roberta Carson, after she was thrust into the role of caregiver for her son Zachary during his 27-month battle with pediatric brain cancer.

Topics: Pharma15, Patient Experience, Most Viewed

Pharma15 Live! jumped at the chance to hear SnapIoT’s Ed Triebell discuss his company’s ground-breaking product, a software platform which allows users to seamlessly connect any smart device to any mobile device—and to any cloud.  

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital, devices, BYOD, provisional device

Pharma15 Live! simply could not resist speaking with Jae Chung, founder of the “Turbo Tax for clinical trials start-up,” goBalto - and his furry friend, the Siberian Husky puppy aptly named Balto. Chung discussed his company’s mission to automate the laborious manual processes related to clinical trial start-up. 

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital, Puppies

Georgia Mitsi spoke with BBK Worldwide’s Aaron Fleishman about her company’s newest app E.V.A — an engagement platform for patients who suffer from chronic neurological conditions. Says Mitsi: “It’s about evaluate, validate and act.”

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, digital, devices, BYOD, provisional device, Most Viewed

During this year’s DPharm 2018, Pharma15 Live! met up with Hassan Kadhim, senior associate director and head of IT clinical trial planning and management at Boehringer Ingelheim, before his presentation on the company’s novel remote clinical trial in the respiratory space. Kadhim reflected about the huge changes that he’s seen in the industry just in the past year. 

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital

In the ongoing battle of BYOD (bring-your-own-device) vs. provision devices, Zachary Javitt, CEO and co-founder of PillTracker, has firmly come down on one side.

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital

Pharma15 Live! sat down with David Levesque to discuss the goal and mission of Andaman7. Throughout the DPharm, one of the main topics was about new ways to allow patients to access their own data.

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, Conferences, digital

Pharma15 Live! sat down Valerie Bowling, drug development industry researcher and founder of DPharm, during the conference to discuss this year’s presentations, and the very popular DPharm Idol competition:

Topics: Pharma15, clinical research, clinical trials, Patient Data, Disruptive Innovation, Conferences